...
首页> 外文期刊>Clinics in liver disease >Secondary Sclerosing Cholangitis. Pathogenesis, Diagnosis, and Management.
【24h】

Secondary Sclerosing Cholangitis. Pathogenesis, Diagnosis, and Management.

机译:继发性硬化性胆管炎。发病机制,诊断和管理。

获取原文
获取原文并翻译 | 示例

摘要

Secondary sclerosing cholangitis (SSC) is an aggressive and rare disease with intricate pathogenesis and multiple causes. Understanding the specific cause underlying each case of SSC is crucial in the clinical management of the disease. Radiologic imaging can help diagnose SSC and hence institute management in a timely manner. Management may encompass simple interventions, such as supportive therapy, antibiotics, and monitoring, or more serious measures, such as surgery, endoscopic intervention, or liver transplantation. Patients with AIDS cholangiopathy have limited therapeutic options and worsened survival. The disease should always be highly suspected in patients with primary sclerosing cholangitis with questionable diagnosis.
机译:继发性硬化性胆管炎(SSC)是一种侵略性罕见疾病,病因复杂,病因复杂。了解每种SSC病例的具体病因对疾病的临床管理至关重要。放射成像可以帮助诊断SSC,从而及时进行管理。管理可能包括简单的干预措施,例如支持疗法,抗生素和监测,或者更严重的措施,例如手术,内窥镜干预或肝移植。艾滋病胆管病患者的治疗选择有限,生存期恶化。在原发性硬化性胆管炎患者中,应始终高度怀疑该病,并诊断为可疑。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号